DOTS in Haiti.
Ollé-Goig, J E.
Int J Tuberc Lung Dis
; 4(3): 282-3, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10751080
New structural classes of antituberculosis agents.
Implementation of the national tuberculosis guidelines on culture and drug sensitivity testing in Guatemala, 2013.
The Global Drug Facility as an intervention in the market for tuberculosis drugs.
Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.
A high content microscopy assay to determine drug activity against intracellular Mycobacterium tuberculosis.
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.
Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach.